Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.
Trial record 31 of 76 for:    stem cell multiple sclerosis

Multi-Center Study Safety of Adipose Derived Mesenchymal Stem Cells for the Treatment of Multiple Sclerosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02326935
Recruitment Status : Terminated
First Posted : December 30, 2014
Last Update Posted : May 22, 2018
Information provided by (Responsible Party):
American CryoStem Corporation

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : May 18, 2018
Actual Study Completion Date : May 18, 2018